Education & Training Services
Compare Stocks
2 / 10Stock Comparison
UTI vs COCO
Revenue, margins, valuation, and 5-year total return — side by side.
Beverages - Non-Alcoholic
UTI vs COCO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Education & Training Services | Beverages - Non-Alcoholic |
| Market Cap | $2.03B | $3.92B |
| Revenue (TTM) | $869M | $659M |
| Net Income (TTM) | $43M | $83M |
| Gross Margin | 24.0% | 37.2% |
| Operating Margin | 6.3% | 14.7% |
| Forward P/E | 46.2x | 41.4x |
| Total Debt | $279M | $13M |
| Cash & Equiv. | $127M | $197M |
UTI vs COCO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| Universal Technical… (UTI) | 100 | 524.4 | +424.4% |
| The Vita Coco Compa… (COCO) | 100 | 508.4 | +408.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UTI vs COCO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
UTI is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 14.0%, EPS growth 50.7%, 3Y rev CAGR 25.9%
- 9.7% 10Y total return vs COCO's 407.7%
- PEG 0.55 vs COCO's 2.75
COCO carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- beta 0.65
- Lower volatility, beta 0.65, Low D/E 3.9%, current ratio 3.62x
- Beta 0.65, current ratio 3.62x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.2% revenue growth vs UTI's 14.0% | |
| Value | PEG 0.55 vs 2.75 | |
| Quality / Margins | 12.6% margin vs UTI's 4.9% | |
| Stability / Safety | Beta 0.65 vs UTI's 0.89, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +96.1% vs UTI's +25.5% | |
| Efficiency (ROA) | 18.1% ROA vs UTI's 5.2%, ROIC 51.2% vs 14.3% |
UTI vs COCO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
UTI vs COCO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
COCO leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UTI and COCO operate at a comparable scale, with $869M and $659M in trailing revenue. COCO is the more profitable business, keeping 12.6% of every revenue dollar as net income compared to UTI's 4.9%. On growth, COCO holds the edge at +37.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $869M | $659M |
| EBITDAEarnings before interest/tax | $78M | $98M |
| Net IncomeAfter-tax profit | $43M | $83M |
| Free Cash FlowCash after capex | $2M | $65M |
| Gross MarginGross profit ÷ Revenue | +24.0% | +37.2% |
| Operating MarginEBIT ÷ Revenue | +6.3% | +14.7% |
| Net MarginNet income ÷ Revenue | +4.9% | +12.6% |
| FCF MarginFCF ÷ Revenue | +0.2% | +9.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.7% | +37.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -95.2% | +61.3% |
Valuation Metrics
UTI leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 32.7x trailing earnings, UTI trades at a 43% valuation discount to COCO's 57.7x P/E. Adjusting for growth (PEG ratio), UTI offers better value at 0.39x vs COCO's 3.83x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.0B | $3.9B |
| Enterprise ValueMkt cap + debt − cash | $2.2B | $3.7B |
| Trailing P/EPrice ÷ TTM EPS | 32.67x | 57.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 46.23x | 41.37x |
| PEG RatioP/E ÷ EPS growth rate | 0.39x | 3.83x |
| EV / EBITDAEnterprise value multiple | 15.56x | 44.62x |
| Price / SalesMarket cap ÷ Revenue | 2.43x | 6.43x |
| Price / BookPrice ÷ Book value/share | 6.26x | 12.42x |
| Price / FCFMarket cap ÷ FCF | 36.70x | 100.45x |
Profitability & Efficiency
COCO leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
COCO delivers a 25.4% return on equity — every $100 of shareholder capital generates $25 in annual profit, vs $13 for UTI. COCO carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to UTI's 0.85x. On the Piotroski fundamental quality scale (0–9), UTI scores 7/9 vs COCO's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +13.0% | +25.4% |
| ROA (TTM)Return on assets | +5.2% | +18.1% |
| ROICReturn on invested capital | +14.3% | +51.2% |
| ROCEReturn on capital employed | +14.7% | +27.4% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.85x | 0.04x |
| Net DebtTotal debt minus cash | $152M | -$184M |
| Cash & Equiv.Liquid assets | $127M | $197M |
| Total DebtShort + long-term debt | $279M | $13M |
| Interest CoverageEBIT ÷ Interest expense | 166.10x | — |
Total Returns (Dividends Reinvested)
UTI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UTI five years ago would be worth $64,886 today (with dividends reinvested), compared to $50,769 for COCO. Over the past 12 months, COCO leads with a +96.1% total return vs UTI's +25.5%. The 3-year compound annual growth rate (CAGR) favors UTI at 82.0% vs COCO's 43.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +48.6% | +28.4% |
| 1-Year ReturnPast 12 months | +25.5% | +96.1% |
| 3-Year ReturnCumulative with dividends | +503.3% | +195.2% |
| 5-Year ReturnCumulative with dividends | +548.9% | +407.7% |
| 10-Year ReturnCumulative with dividends | +970.1% | +407.7% |
| CAGR (3Y)Annualised 3-year return | +82.0% | +43.4% |
Risk & Volatility
COCO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
COCO is the less volatile stock with a 0.65 beta — it tends to amplify market swings less than UTI's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. COCO currently trades 98.6% from its 52-week high vs UTI's 91.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 0.65x |
| 52-Week HighHighest price in past year | $40.41 | $69.58 |
| 52-Week LowLowest price in past year | $21.29 | $30.54 |
| % of 52W HighCurrent price vs 52-week peak | +91.4% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 59.7 | 76.9 |
| Avg Volume (50D)Average daily shares traded | 594K | 1.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates UTI as "Buy" and COCO as "Buy". Consensus price targets imply 32.7% upside for UTI (target: $49) vs -1.1% for COCO (target: $68).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $49.00 | $67.86 |
| # AnalystsCovering analysts | 11 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.3% |
COCO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). UTI leads in 2 (Valuation Metrics, Total Returns).
UTI vs COCO: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is UTI or COCO a better buy right now?
For growth investors, The Vita Coco Company, Inc.
(COCO) is the stronger pick with 18. 2% revenue growth year-over-year, versus 14. 0% for Universal Technical Institute, Inc. (UTI). Universal Technical Institute, Inc. (UTI) offers the better valuation at 32. 7x trailing P/E (46. 2x forward), making it the more compelling value choice. Analysts rate Universal Technical Institute, Inc. (UTI) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UTI or COCO?
On trailing P/E, Universal Technical Institute, Inc.
(UTI) is the cheapest at 32. 7x versus The Vita Coco Company, Inc. at 57. 7x. On forward P/E, The Vita Coco Company, Inc. is actually cheaper at 41. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Universal Technical Institute, Inc. wins at 0. 55x versus The Vita Coco Company, Inc. 's 2. 75x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — UTI or COCO?
Over the past 5 years, Universal Technical Institute, Inc.
(UTI) delivered a total return of +548. 9%, compared to +407. 7% for The Vita Coco Company, Inc. (COCO). Over 10 years, the gap is even starker: UTI returned +970. 1% versus COCO's +407. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UTI or COCO?
By beta (market sensitivity over 5 years), The Vita Coco Company, Inc.
(COCO) is the lower-risk stock at 0. 65β versus Universal Technical Institute, Inc. 's 0. 89β — meaning UTI is approximately 37% more volatile than COCO relative to the S&P 500. On balance sheet safety, The Vita Coco Company, Inc. (COCO) carries a lower debt/equity ratio of 4% versus 85% for Universal Technical Institute, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — UTI or COCO?
By revenue growth (latest reported year), The Vita Coco Company, Inc.
(COCO) is pulling ahead at 18. 2% versus 14. 0% for Universal Technical Institute, Inc. (UTI). On earnings-per-share growth, the picture is similar: Universal Technical Institute, Inc. grew EPS 50. 7% year-over-year, compared to 26. 6% for The Vita Coco Company, Inc.. Over a 3-year CAGR, UTI leads at 25. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UTI or COCO?
The Vita Coco Company, Inc.
(COCO) is the more profitable company, earning 11. 7% net margin versus 7. 5% for Universal Technical Institute, Inc. — meaning it keeps 11. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: COCO leads at 13. 6% versus 10. 0% for UTI. At the gross margin level — before operating expenses — UTI leads at 49. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UTI or COCO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Universal Technical Institute, Inc. (UTI) is the more undervalued stock at a PEG of 0. 55x versus The Vita Coco Company, Inc. 's 2. 75x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Vita Coco Company, Inc. (COCO) trades at 41. 4x forward P/E versus 46. 2x for Universal Technical Institute, Inc. — 4. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UTI: 32. 7% to $49. 00.
08Which pays a better dividend — UTI or COCO?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is UTI or COCO better for a retirement portfolio?
For long-horizon retirement investors, Universal Technical Institute, Inc.
(UTI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), +970. 1% 10Y return). Both have compounded well over 10 years (UTI: +970. 1%, COCO: +407. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UTI and COCO?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: UTI is a small-cap quality compounder stock; COCO is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.